The baboon model of pertussis: effective use and lessons for pertussis vaccines

References

• Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18(2):326-82
   PubMed Web of Science ®Google Scholar
• Heininger U. Update on pertussis in children. Expert Rev Anti Infect Ther 2010;8(2):163-73
   PubMed Web of Science ®Google Scholar
• Haberling DL, Holman RC, Paddock CD, Murphy TV. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J 2009;28(3):194-8
   PubMedGoogle Scholar
• Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr 2012;161(6):1091-6
   PubMed Web of Science ®Google Scholar
• Clark TA. Changing pertussis epidemiology: everything old is new again. J Infect Dis 2014;209(7):978-81
   PubMed Web of Science ®Google Scholar
• Libster R, Edwards KM. Re-emergence of pertussis: what are the solutions? Expert Rev Vaccines 2012;11(11):1331-46
   PubMed Web of Science ®Google Scholar
• Zhang L, Prietsch SO, Axelsson I, Halperin SA. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2012;3:CD001478
   Google Scholar
• Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996;334(6):341-8
   PubMed Web of Science ®Google Scholar
• Gustafsson L, Hallander HO, Olin P, et al. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334(6):349-55
   PubMed Web of Science ®Google Scholar
• Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA 2012;308(20):2126-32
   PubMed Web of Science ®Google Scholar
• CDC. Pertussis: surveillance and reporting. 2014. Available from: www.cdc.gov/pertussis/surv-reporting.html
   Google Scholar
• Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect 2013;1-13
   Google Scholar
• WHO. SAGE Pertussis Working Group Background paper. 2014. Available from: www.who.int/entity/immunization/sage/meetings/2014/april/1_Pertussis_background_FINAL4_web.pdf?ua=1
   Google Scholar
• Australian Government Department of Health. National notifiable diseases surveillance system. 2014. Available from: www9.health.gov.au/cda/source/cda-index.cfm
   Google Scholar
• Public Health England. Laboratory confirmed cases of Pertussis infection by laboratory method, year and quarter, England: 2002-2013. 2014. Available from: www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317133571358
   Google Scholar
• Friedrich MJ. Research aims to boost pertussis control. JAMA 2011;306(1):27-9
   PubMedGoogle Scholar
• Poland GA. Pertussis outbreaks and pertussis vaccines: new insights, new concerns, new recommendations? Vaccine 2012;30(49):6957-9
   PubMed Web of Science ®Google Scholar
• CDC. National, state, and local area vaccination coverage among children aged 19-35 months – United States, 2011. Morb Mortal Wkly Rep 2012;61:689-96
   PubMedGoogle Scholar
• Higgs R, Higgins SC, Ross PJ, Mills KH. Immunity to the respiratory pathogen Bordetella pertussis. Mucosal Immunol 2012;5(5):485-500
   PubMed Web of Science ®Google Scholar
• Cherry JD. Epidemic pertussis in 2012 – the resurgence of a vaccine-preventable disease. N Engl J Med 2012;367(9):785-7
   PubMed Web of Science ®Google Scholar
• Witt MA, Arias L, Katz PH, et al. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis 2013;56(9):1248-54
   PubMed Web of Science ®Google Scholar
• Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med 2013;368(6):581-2
   PubMed Web of Science ®Google Scholar
• Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA 2012;308(5):454-6
   PubMed Web of Science ®Google Scholar
• Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics 2013;131(6):e1716-22
   PubMed Web of Science ®Google Scholar
• Klein NP, Bartlett J, Rowhani-Rahbar A, et al. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med 2012;367(11):1012-19
   PubMed Web of Science ®Google Scholar
• Tartof SY, Lewis M, Kenyon C, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013;131(4):e1047-52
   PubMed Web of Science ®Google Scholar
• Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012;54(12):1730-5
   PubMed Web of Science ®Google Scholar
• CDC. Pertussis epidemic – Washington, 2012. MMWR Morb Mortal Wkly Rep 2012;61(28):517-22
   PubMedGoogle Scholar
• Barlow RS, Reynolds LE, Cieslak PR, Sullivan AD. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012. Clin Infect Dis 2014;58(11):1523-9
   PubMed Web of Science ®Google Scholar
• Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci USA 2014;111(2):787-92
   PubMed Web of Science ®Google Scholar
• de Greeff SC, de Melker HE, van Gageldonk PG, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 2010;5(12):e14183
   PubMed Web of Science ®Google Scholar
• Lai FY, Thoon KC, Ang LW, et al. Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: waning pertussis immunity in a highly immunized population and the need for adolescent booster doses. Vaccine 2012;30(24):3566-71
   PubMedGoogle Scholar
• Merkel TJ, Halperin SA. Nonhuman primate and human challenge models of pertussis. J Infect Dis 2014;209(Suppl 1):S20-3
   PubMedGoogle Scholar
• van der Ark AA, Hozbor DF, Boog CJ, et al. Resurgence of pertussis calls for re-evaluation of pertussis animal models. Expert Rev Vaccines 2012;11(9):1121-37
   PubMed Web of Science ®Google Scholar
• Elahi S, Holmstrom J, Gerdts V. The benefits of using diverse animal models for studying pertussis. Trends Microbiol 2007;15(10):462-8
   PubMedGoogle Scholar
• Culotta C, Harvey D, Gordon E. Whooping cough II: experimental study. J Pediatr 1935;6:743-52
   Google Scholar
• Huang CC, Chen PM, Kuo JK, et al. Experimental Whooping cough. N Engl J Med 1962;266:105-11
   PubMed Web of Science ®Google Scholar
• Lin T. Experimental whooping cough in monkey. J Formos Med Ass 1958;57:53-62
   Google Scholar
• Sauer L, Hambrecht L. Experimental whooping cough. Am J Dis Child 1929;37:732-44
   Google Scholar
• Rich AR, Long PH, Brown JH, et al. Experiments upon the cause of whooping cough. Science 1932;76(1971):330-1
   PubMedGoogle Scholar
• Shibley G. Etiology of whooping cough. Proc Soc Exp Biol Med 1934;31:576-9
   Google Scholar
• Berger JT, Carcillo JA, Shanley TP, et al. Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med 2013;14(4):356-65
   PubMed Web of Science ®Google Scholar
• Sprunt DH, Martin DS, McDearman S. Results of the intratracheal injection of the bordet-gengou bacillus in the monkey and rabbit. J Exp Med 1938;67(2):309-22
   PubMedGoogle Scholar
• Warfel JM, Beren J, Kelly VK, et al. Nonhuman primate model of pertussis. Infect Immun 2012;80(4):1530-6
   PubMed Web of Science ®Google Scholar
• Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis 2012;206(6):902-6
   PubMed Web of Science ®Google Scholar
• Tardif SD, Coleman K, Hobbs TR, Lutz C. IACUC review of nonhuman primate research. ILAR J 2013;54(2):234-45
   PubMedGoogle Scholar
• Perry DL, Bollinger L, White GL. The Baboon (Papio spp.) as a model of human Ebola virus infection. Viruses 2012;4(10):2400-16
   PubMedGoogle Scholar
• Shearer MH, Dark RD, Chodosh J, Kennedy RC. Comparison and characterization of immunoglobulin G subclasses among primate species. Clin Diagn Lab Immunol 1999;6(6):953-8
   PubMedGoogle Scholar
• Hefty PS, Brooks CS, Jett AM, et al. OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients. J Clin Microbiol 2002;40(11):4256-65
   PubMedGoogle Scholar
• Wolf RF, Papin JF, Hines-Boykin R, et al. Baboon model for West Nile virus infection and vaccine evaluation. Virology 2006;355(1):44-51
   PubMed Web of Science ®Google Scholar
• Papin JF, Wolf RF, Kosanke SD, et al. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol 2013;304(8):L530-9
   PubMedGoogle Scholar
• Stearns-Kurosawa D, Lupu F, Taylor FJ, et al. Sepsis and pathophysiology of anthrax in a nonhuman primate model. Am J Pathol 2006;169(2):433-44
   PubMedGoogle Scholar
• Warfel JM, Merkel TJ. Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates. Mucosal Immunol 2013;6(4):787-96
   PubMed Web of Science ®Google Scholar
• Schure RM, Hendrikx LH, de Rond LG, et al. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-year-old Dutch children. Clin Vaccine Immunol 2012;19(11):1879-86
   PubMedGoogle Scholar
• Schure RM, Hendrikx LH, de Rond LG, et al. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination. Clin Vaccine Immunol 2013;20(9):1388-95
   PubMedGoogle Scholar
• Kolls JK, Khader SA. The role of Th17 cytokines in primary mucosal immunity. Cytokine Growth Factor Rev 2010;21(6):443-8
   PubMed Web of Science ®Google Scholar
• Ye P, Garvey PB, Zhang P, et al. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am J Respir Cell Mol Biol 2001;25(3):335-40
   PubMed Web of Science ®Google Scholar
• Ross PJ, Sutton CE, Higgins S, et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013;9(4):e1003264
   PubMed Web of Science ®Google Scholar
• Zhang X, Goel T, Goodfield LL, et al. Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol 2011;186(8):4895-904
   PubMedGoogle Scholar
• Andreasen C, Powell DA, Carbonetti NH. Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS One 2009;4(9):e7079
   PubMed Web of Science ®Google Scholar
• Plotkin SA. The pertussis problem. Clin Infect Dis 2014;58(6):830-3
   PubMed Web of Science ®Google Scholar
• Asokanathan C, Corbel M, Xing D. A CpG-containing oligodeoxynucleotide adjuvant for acellular pertussis vaccine improves the protective response against Bordetella pertussis. Hum Vaccin Immunother 2013;9:2
   Google Scholar
• Fedele G, Bianco M, Debrie AS, et al. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol 2011;186(9):5388-96
   PubMed Web of Science ®Google Scholar
• Feunou PF, Bertout J, Locht C. T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis. PLoS One 2010;5(4):e10178
   PubMedGoogle Scholar
• Farizo KM, Burns DL, Finn TM, et al. Clinical evaluation of pertussis vaccines: US Food and Drug Administration regulatory considerations. J Infect Dis 2014;209(Suppl 1):S28-31
   PubMedGoogle Scholar
• Plotkin SA. Complex correlates of protection after vaccination. Clin Infect Dis 2013;56(10):1458-65
   PubMed Web of Science ®Google Scholar
• Meade BD, Plotkin SA, Locht C. Possible options for new pertussis vaccines. J Infect Dis 2014;209(Suppl 1):S24-7
   PubMed Web of Science ®Google Scholar
• Taranger J, Trollfors B, Lagergård T, et al. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis 2000;181(3):1010-13
   PubMed Web of Science ®Google Scholar
• Cherry JD, Gornbein J, Heininger U, Stehr K. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 1998;16(20):1901-6
   PubMed Web of Science ®Google Scholar
• Namachivayam P, Shimizu K, Butt W. Pertussis: severe clinical presentation in pediatric intensive care and its relation to outcome. Pediatr Crit Care Med 2007;8(3):207-11
   PubMedGoogle Scholar
• Halasa NB, Barr FE, Johnson JE, Edwards KM. Fatal pulmonary hypertension associated with pertussis in infants: does extracorporeal membrane oxygenation have a role? Pediatrics 2003;112(6 Pt 1):1274-8
   PubMedGoogle Scholar
• Paddock CD, Sanden GN, Cherry JD, et al. Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis 2008;47(3):328-38
   PubMed Web of Science ®Google Scholar
• Ulloa-Gutierrez R, Boza R, Carvajal-Riggioni D, Baltodano A. Pertussis: should we improve intensive care management or vaccination strategies? Expert Rev Vaccines 2011;10(1):49-53
   PubMed Web of Science ®Google Scholar
• Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23(11):985-9
   PubMed Web of Science ®Google Scholar
• Kowalzik F, Barbosa AP, Fernandes VR, et al. Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatr Infect Dis J 2007;26(3):238-42
   PubMed Web of Science ®Google Scholar
• Wendelboe AM, Hudgens MG, Poole C, Van Rie A. Estimating the role of casual contact from the community in transmission of Bordetella pertussis to young infants. Emerg Themes Epidemiol 2007;4:15
   PubMedGoogle Scholar
• Castagnini LA, Healy CM, Rench MA, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012;54(1):78-84
   PubMed Web of Science ®Google Scholar
• Terranella A, Asay GR, Messonnier ML, et al. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 2013;131(6):e1748-56
   PubMed Web of Science ®Google Scholar
• Belloni C, De Silvestri A, Tinelli C, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003;111(5 Pt 1):1042-5
   PubMedGoogle Scholar
• Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010;29(3):209-15
   PubMed Web of Science ®Google Scholar
• CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months – advisory committee on immunization practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep 2011;60(41):1424-6
   PubMedGoogle Scholar
• CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (tdap) in pregnant women advisory committee on immunization practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62(7):131-5
   PubMed Web of Science ®Google Scholar
• Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011;204(4):334e331-5
   Google Scholar
• Leuridan E, Hens N, Peeters N, et al. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011;30(7):608-10
   PubMedGoogle Scholar
• Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014;311(17):1760-9
   PubMed Web of Science ®Google Scholar
• Warfel JM, Papin JF, Wolf RF, et al. Maternal and Neonatal Vaccination Protects Newborn Baboons From Pertussis Infection. J Infect Dis 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014;133(3):e513-19
   PubMed Web of Science ®Google Scholar
• Nilsson L, Lepp T, von Segebaden K, et al. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: analyses of 10 years of pertussis surveillance. Vaccine 2012;30(21):3239-47
   PubMed Web of Science ®Google Scholar
• Halasa NB, O’Shea A, Shi JR, et al. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008;153(3):327-32
   PubMed Web of Science ®Google Scholar
• Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008;152(5):655-60. 660 e651
   PubMed Web of Science ®Google Scholar
• Hewlett EL, Burns DL, Cotter PA, et al. Pertussis pathogenesis – what we know and what we don’t know. J Infect Dis 2014;209(7):982-5
   PubMedGoogle Scholar
• Melvin JA, Scheller EV, Miller JF, Cotter PA. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 2014;12(4):274-88
   PubMed Web of Science ®Google Scholar
• Eby JC, Gray MC, Warfel JM, et al. Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection. Infect Immun 2013;81(5):1390-8
   PubMed Web of Science ®Google Scholar
• Pawloski LC, Queenan AM, Cassiday PK, et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States. Clin Vaccine Immunol 2014;21(2):119-25
   PubMed Web of Science ®Google Scholar
• Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 2013;368(6):583-4
   PubMedGoogle Scholar
• Lam C, Octavia S, Ricafort L, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis 2014;20(4):626-33
   PubMed Web of Science ®Google Scholar
• Hegerle N, Paris AS, Brun D, et al. Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 2012;18(9):E340-6
   PubMedGoogle Scholar
• Otsuka N, Han HJ, Toyoizumi-Ajisaka H, et al. Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 2012;7(2):e31985
   PubMed Web of Science ®Google Scholar
• Bart MJ, Harris SR, Advani A, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 2014;5:2
   PubMedGoogle Scholar
• Bodilis H, Guiso N. Virulence of pertactin-negative Bordetella pertussis isolates from infants, France. Emerg Infect Dis 2013;19(3):471-4
   PubMed Web of Science ®Google Scholar
• van Gent M, van Loo IH, Heuvelman KJ, et al. Studies on Prn variation in the mouse model and comparison with epidemiological data. PLoS One 2011;6(3):e18014
   PubMedGoogle Scholar